SEC Filings for Ligand Pharmaceuticals Incorporated (LGND)

$ 66.79   -6.13 (-8.41%) Volume: 745.86k 4:00 PM EDT 27-Mar-2020
Filing Type:
Form TypeForm DescriptionPagesDateView
8-A12GRegistration of securities [Section 12(g)]209/30/1996
S-8Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans709/27/1996
S-3Registration statement under Securities Act of 1933309/25/1996
10-QGeneral form for quarterly reports under Section 13 or 15(d)608/14/1996
10-QGeneral form for quarterly reports under Section 13 or 15(d)205/09/1996
SC 13G/A[Amend] Statement of acquisition of beneficial ownership by individuals102/06/1996
SC 13D/A[Amend] General statement of acquisition of beneficial ownership112/22/1994
SC 13DGeneral statement of acquisition of beneficial ownership409/13/1994
100101102103104105106107108109110111112113114
Next
>
Last
�>>